The cell wall of T-cell fragments targeting PD-L1 of cancerous cells for immunotherapy for cancer kill tumor cells directly and raise the level of CD8+ T cells to promote effector cytokine release to further enhance tumor killing [66]. Here, CD8A is linked to neoplasm.